HC Andersen Capital: NeoDynamics - Magnus Precht on Pulse technology in the US market
NeoDynamics’ Magnus Precht updates us on the US market. On Tuesday 1[st] of March 2022, NeoDynamics filed a registration application for its innovative Pulse biopsy system NeoNavia® with the US Food and Drug Administration, FDA.Read the press release here . We have interviewed Magnus Precht to explain the characteristics of the US Market. Watch the interview here . At NeoDynamics, Magnus will lead the commercialization in the US